Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
Mayne Pharma Group (ASX:MYX) shares closed at AUD 3.35, up 3.72% on 20 August 2026. The movement reflects a positiveTrading sessionas investors continue to assess the company’s specialty pharmaceutical portfolio, Women’s Health growth strategy and operational transition.
Oceania Healthcare Limited (ASX:OCA) shares closed at AUD 0.67, up 0.75% on 20 August 2026. The movement reflects a slightly positiveTrading sessionas investors continue to assess the company’s retirement village platform, aged care operations and ongoingBusinessreset.
Racura Oncology Limited (ASX:RAC) shares closed at AUD 2.10, down 0.94% on 20 August 2026. The movement reflects a slightly weakerTrading sessionas investors continue to assess the company’s oncology development programs, clinical milestones and funding position.
AFT Pharmaceuticals (ASX:AFP) shares closed at AUD 3.60, down 5.26% on 20 August 2026. The movement reflects a weakerTrading sessionas investors continue to assess the company’s pharmaceutical portfolio, international growth strategy andInvestmentinto future product opportunities.
Starpharma Holdings (ASX:SPL) shares closed at AUD 0.76, up 4.83% on 20 August 2026. The movement reflects a positiveTrading sessionas investors continue to assess the company’s dendrimer technology platform, oncology pipeline and partnership strategy.
Healius Limited (ASX:HLS) shares closed at AUD 0.465, up 10.71% on 20 August 2026. The movement reflects a strongerTrading sessionas investors assessed the company’s FY26 performance, pathologyMarginimprovement and ongoing transformation initiatives.
Monash IVF Group (ASX:MVF) shares closed at AUD 0.725, up 0.69% on 20 August 2026. The movement reflects a slightly positiveTrading sessionas investors continue to assess the company’s fertility services platform, patientDemandtrends and operational performance.
Pacific Edge Limited (ASX:PEB) shares closed at AUD 0.21, down 4.55% on 20 August 2026. The movement reflects a weakerTrading sessionas investors continue to assess the company’s bladder cancer diagnostics platform, Medicare reimbursement pathway and commercial recovery strategy.
Vitrafy Life Sciences (ASX:VFY) shares closed at AUD 4.10, down 5.31% on 20 August 2026. The movement reflects a weakerTrading sessionas investors continue to assess the company’s transition from technology development towards commercial deployment.
AVITA Medical (ASX:AVH) shares closed at AUD 2.82, up 4.06% on 20 August 2026. The movement reflects a positiveTrading sessionas investors continue to assess the company’s acute wound care portfolio, commercial execution and pathway towards cash flow breakeven.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…